BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 7430635)

  • 1. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S; Fidler IJ
    J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
    Fidler IJ; Schroit AJ
    J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
    Sone S; Poste G; Fidler IJ
    J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S; Tsubura E
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G; Kirsh R; Fogler WE; Fidler IJ
    Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
    J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
    Daemen T; Veninga A; Roerdink FH; Scherphof GL
    Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
    Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
    Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I; Fidler IJ
    J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
    J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
    Phillips NC; Moras ML; Chedid L; Lefrancier P; Bernard JM
    Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D; Jeannin JF; Martin F
    C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. I. Macrophage-mediated tumor cell lysis.
    Geetha B; Sodhi A
    Nat Immun Cell Growth Regul; 1989; 8(2):100-7. PubMed ID: 2503714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
    Reisser D; Jeannin JF; Lagadec P; Martin F
    J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ; Fidler IJ
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
    Sone S; Mutsuura S; Ogawara M; Tsubura E
    J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functions of multinucleated giant cells formed by fusing rat alveolar macrophages with lymphokines containing macrophage fusion factor.
    Sone S
    Lymphokine Res; 1984; 3(4):163-73. PubMed ID: 6333567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
    Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
    Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes.
    Sone S; Fidler IJ
    Cell Immunol; 1981 Jan; 57(1):42-50. PubMed ID: 7214534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.